Increased risk of erectile dysfunction among males with central serous chorioretinopathy - A retrospective cohort study

Acta Ophthalmologica

Volumn 91, Issue 7, 2013, Pages 666-671

  Tsai, Der Chong ^a   Huang, Chin Chou ^a,b   Chen, Shih Jen ^b   Chou, Pesus ^a   Chung, Chia Min ^c   Chan, Wan Leong ^b   Huang, Po Hsun ^a,b   Lin, Shing Jong ^a,b   Chen, Jaw Wen ^a,b   Leu, Hsin Bang ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

Author keywords

central serous chorioretinopathy; erectile dysfunction; national health insurance research database; retrospective cohort study

Indexed keywords

ADULT; AGE; ARTICLE; CENTRAL SEROUS RETINOPATHY; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; DRUG USE; ERECTILE DYSFUNCTION; GEOGRAPHY; HUMAN; INCIDENCE; INCOME; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL METHOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT;

CENTRAL SEROUS CHORIORETINOPATHY; ERECTILE DYSFUNCTION; NATIONAL HEALTH INSURANCE RESEARCH DATABASE; RETROSPECTIVE COHORT STUDY;

ADULT; CENTRAL SEROUS CHORIORETINOPATHY; COHORT STUDIES; DATABASES, FACTUAL; ERECTILE DYSFUNCTION; HUMANS; MALE; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; RETROSPECTIVE STUDIES; RISK FACTORS; TAIWAN; YOUNG ADULT;

EID: 84885954531     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/j.1755-3768.2012.02528.x     Document Type: Article

References (41)

1. Aversa A, Bruzziches R, Francomano D, Natali M, Gareri P, &, Spera G, (2010): Endothelial dysfunction and erectile dysfunction in the aging man. Int J Urol 17: 38-47.
2. Ayta IA, McKinlay JB, &, Krane RJ, (1999): The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences. BJU Int 84: 50-56.
3. Beutelspacher SC, Serbecic N, Barash H, Burgansky-Eliash Z, Grinvald A, &, Jonas JB, (2011): Central serous chorioretinopathy shows reduced retinal flow circulation in retinal function imaging (RFI). Acta Ophthalmol 89: e479-e482.
4. Bouzas EA, Scott MH, Mastorakos G, Chrousos GP, &, Kaiser-Kupfer MI, (1993): Central serous chorioretinopathy in endogenous hypercortisolism. Arch Ophthalmol 111: 1229-1233.
5. Bouzas EA, Karadimas P, &, Pournaras CJ, (2002): Central serous chorioretinopathy and glucocorticoids. Surv Ophthalmol 47: 431-448.
6. Caccavale A, Imparato M, Romanazzi F, Negri A, Porta A, &, Ferentini F, (2009): A new strategy of treatment with low-dosage acetyl salicylic acid in patients affected by central serous chorioretinopathy. Med Hypotheses 73: 435-437.
7. Caccavale A, Romanazzi F, Imparato M, Negri A, Morano A, &, Ferentini F, (2011): Central serous chorioretinopathy: a pathogenetic model. Clin Ophthalmol 5: 239-243.
8. Chou KT, Huang CC, Chen YM, Perng DW, Chao HS, Chan WL, &, Leu HB, (2011): Asthma and risk of erectile dysfunction-a nationwide population-based study. J Sex Med 8: 1754-1760.
9. Chrousos GP, &, Gold PW, (1992): The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. JAMA 267: 1244-1252.
10. Chung SD, Chen YK, Lin HC, &, Lin HC, (2011a): Increased risk of stroke among men with erectile dysfunction: a nationwide population-based study. J Sex Med 8: 240-246.
11. Chung SD, Kang JH, Liao CH, Chiu KM, &, Lin HC, (2011b): Increased risk for cancer following erectile dysfunction: a nationwide population-based follow-up study. J Sex Med 8: 1513-1520.
12. Costa C, &, Virag R, (2009): The endothelial-erectile dysfunction connection: an essential update. J Sex Med 6: 2390-2404.
13. Ficker L, Vafidis G, While A, &, Leaver P, (1988): Long-term follow-up of a prospective trial of argon laser photocoagulation in the treatment of central serous retinopathy. Br J Ophthalmol 72: 829-834.
14. Garg SP, Dada T, Talwar D, &, Biswas NR, (1997): Endogenous cortisol profile in patients with central serous chorioretinopathy. Br J Ophthalmol 81: 962-964.
15. Gelber GS, &, Schatz H, (1987): Loss of vision due to central serous chorioretinopathy following psychological stress. Am J Psychiatry 144: 46-50.
16. Granata A, Bancroft J, &, Del Rio G, (1995): Stress and the erectile response to intracavernosal prostaglandin E1 in men with erectile dysfunction. Psychosom Med 57: 336-344.
17. Haimovici R, Rumelt S, &, Melby J, (2003): Endocrine abnormalities in patients with central serous chorioretinopathy. Ophthalmology 110: 698-703.
18. Ho JD, Liou SW, &, Lin HC, (2009): Retinal vein occlusion and the risk of stroke development: a five-year follow-up study. Am J Ophthalmol 147: 283-290.
19. Hu CC, Ho JD, &, Lin HC, (2009): Retinal vein occlusion and the risk of acute myocardial infarction: a 3-year follow-up study. Br J Ophthalmol 93: 717-720.
20. Iida T, Kishi S, Hagimura N, &, Shimizu K, (1999): Persistent and bilateral choroidal vascular abnormalities in central serous chorioretinopathy. Retina 19: 508-512.
21. Iijima H, Iida T, Murayama K, Imai M, &, Gohdo T, (1999): Plasminogen activator inhibitor-1 in central serous chorioretinopathy. Am J Ophthalmol 127: 477-478.
22. Inman BA, Sauver JL, Jacobson DJ, McGree ME, Nehra A, Lieber MM, Roger VL, &, Jacobsen SJ, (2009): A population-based, longitudinal study of erectile dysfunction and future coronary artery disease. Mayo Clin Proc 84: 108-113.
23. Jeremy JY, Angelini GD, Khan M, Mikhailidis DP, Morgan RJ, Thompson CS, Bruckdorfer KR, &, Naseem KM, (2000): Platelets oxidant stress and erectile dysfunction: an hypothesis. Cardiovasc Res 46: 50-54.
24. Kirby M, Jackson G, Betteridge J, &, Friedli K, (2001): Is erectile dysfunction a marker for cardiovascular disease? Int J Clin Pract 55: 614-618.
25. Kitaya N, Nagaoka T, Hikichi T, Sugawara R, Fukui K, Ishiko S, &, Yoshida A, (2003): Features of abnormal choroidal circulation in central serous chorioretinopathy. Br J Ophthalmol 87: 709-712.
26. Kitzmann AS, Pulido JS, Diehl NN, Hodge DO, &, Burke JP, (2008): The incidence of central serous chorioretinopathy in Olmsted County, Minnesota, 1980-2002. Ophthalmology 115: 169-173.
27. Kobori Y, Koh E, Sugimoto K, et al., (2009): The relationship of serum and salivary cortisol levels to male sexual dysfunction as measured by the International Index of Erectile Function. Int J Impot Res 21: 207-212.
28. Mann RM, Riva CE, Stone RA, Barnes GE, &, Cranstoun SD, (1995): Nitric oxide and choroidal blood flow regulation. Invest Ophthalmol Vis Sci 36: 925-930.
29. Nicolosi A, Moreira ED Jr, Shirai M, Bin Mohd Tambi MI, &, Glasser DB, (2003): Epidemiology of erectile dysfunction in four countries: cross-national study of the prevalence and correlates of erectile dysfunction. Urology 61: 201-206.
30. Nicolosi A, Laumann EO, Glasser DB, Moreira ED Jr, Paik A, &, Gingell C,; Global Study of Sexual Attitudes and Behaviors Investigators' Group (2004): Sexual behavior and sexual dysfunctions after age 40: the global study of sexual attitudes and behaviors. Urology 64: 991-997.
31. NIH Consensus Conference. Impotence (1993): NIH Consensus Development Panel on Impotence. JAMA 270: 83-90.
32. Nyklicek I, Bosch JA, &, Amerongen AV, (2005): A generalized physiological hyperreactivity to acute stressors in hypertensives. Biol Psychol 70: 44-51.
33. Shin D, Pregenzer G Jr, &, Gardin JM, (2011): Erectile dysfunction: a disease marker for cardiovascular disease. Cardiol Rev 19: 5-11.
34. Uckert S, Fuhlenriede MH, Becker AJ, Stief CG, Scheller F, Knapp WH, &, Jonas U, (2003): Is there an inhibitory role of cortisol in the mechanism of male sexual arousal and penile erection? Urol Res 31: 402-406.
35. Virag R, Bouilly P, &, Frydman D, (1985): Is impotence an arterial disorder? A study of arterial risk factors in 440 impotent men. Lancet 1: 181-184.
36. Wakakura M, &, Ishikawa S, (1984): Central serous chorioretinopathy complicating systemic corticosteroid treatment. Br J Ophthalmol 68: 329-331.
37. Wang M, Munch IC, Hasler PW, Prünte C, &, Larsen M, (2008): Central serous chorioretinopathy. Acta Ophthalmol 86: 126-145.
38. Williams RB Jr, Lane JD, Kuhn CM, Melosh W, White AD, &, Schanberg SM, (1982): Type A behavior and elevated physiological and neuroendocrine responses to cognitive tasks. Science 218: 483-485.
39. Worrall NK, Misko TP, Sullivan PM, Hui JJ, Rodi CP, &, Ferguson TB Jr, (1996): Corticosteroids inhibit expression of inducible nitric oxide synthase during acute cardiac allograft rejection. Transplantation 61: 324-328.
40. Yamada R, Yamada S, Ishii A, &, Tane S, (1993): Evaluation of tissue plasminogenactivator and plasminogen activator inhibitor-1 in blood obtained frompatients of idiopathic central serous chorioretinopathy. Nippon GankaGakkai Zasshi 97: 955-960.
41. Yannuzzi LA, (1987): Type a behavior and central serous chorioretinopathy. Retina 7: 111-131.